AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Learn the scenarios where index funds outperform target date funds, with emphasis on fees, control, and asset allocation flexibility.
26,348 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Bitcoin hovers near a pivotal zone as bulls and bears clash. Analysts warn of a potential break below key supports, s...
As mortgage defaults foreclosures surging reshape housing markets, savvy investors can protect portfolios with discip...
A quick intervention by a cashier prevented a senior from losing thousands to a Bitcoin scam. This piece breaks down ...
AMD tracks a rapid data-center rebound with 57% YoY growth, challenging Nvidia as hyperscalers back MI450. Investors ...
Bitcoin faces a pivotal moment as a btc’s hidden liquidity cluster near crucial price blocks could dictate the next l...
The high-stakes world of luxury real estate can turn on a dime. In the case of jennifer lopez’s $50m mansion, escrow ...
Age-verification efforts aimed at safeguarding minors are sparking a broader push toward universal online IDs, with p...
If you think it's late Vertiv, you're not alone. Yet the data-center and AI infrastructure cycle still offers upside....
Ethereum rebounds from a mid-$1,700s slip, but the rebound sits at a critical crossroad. The question: is this a reli...
New data shows high-end metro areas are turning over listings faster than mid-priced markets, upending expectations a...
AST SpaceMobile and Globalstar chart divergent paths toward 2026 as they push new revenue streams and cash flow.